Clinical evidences on the DPP-4 inhibitor sitagliptin suggests it is associated with a decreased risk of prostate cancer [106, 110], and long-term administration of this agent may have potential benefits for breast cancer [96]
Symptoms: lightheadedness, shakiness, fatigue, blurred vision Management: Always pair with post-workout carbs (e.g., CLEAN CARBS) and avoid fasted use unless experienced IGF1 induces insulin-like effects, including hypoglycemia, particularly at supraphysiologic doses. LeRoith et al., Diabetes Reviews Injection Site Irritation Repeated injections, especially IM, may cause localized inflammation or discomfort
Fortified foods offer another option
Will I lose muscle while I lose weight
Calcium : supports muscle, nerve, and other functions